The Impact of COVID-19 on the Health-Care Workforce: from Heroes to Zeroes?

le Czernin, Johannes
Foilsithe in J Nucl Med (2020)

Is conflict of interest in our best interest?

le Beyer, Thomas, Czernin, Johannes
Foilsithe 2010

The Potential of PET/MRI Imaging in Oncology: a Comment to a Summary Report of the First PET/MRI Workshop in Tuebingen in 2012

le Czernin, Johannes, Herrmann, Ken
Foilsithe 2013

A Conversation Between Nora Volkow and Johannes Czernin

le Volkow, Nora, Czernin, Johannes
Foilsithe in J Nucl Med (2019)

Molecular Mechanisms of Bone (18)F-NaF Deposition

le Czernin, Johannes, Satyamurthy, Nagichettiar, Schiepers, Christiaan
Foilsithe 2010

(18)F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients

le Spick, Claudio, Herrmann, Ken, Czernin, Johannes
Foilsithe in J Nucl Med (2016)

PET Imaging of Prostate Cancer Using (11)C-Acetate

le Czernin, Johannes, Benz, Matthias R., Allen-Auerbach, Martin S.
Foilsithe 2009

Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer

le Lee, Percy, Kupelian, Patrick, Czernin, Johannes, Ghosh, Partha
Foilsithe 2012

The future of hybrid imaging—part 3: PET/MR, small-animal imaging and beyond

le Beyer, Thomas, Freudenberg, Lutz S., Czernin, Johannes, Townsend, David W.
Foilsithe 2011

The future of hybrid imaging—part 1: hybrid imaging technologies and SPECT/CT

le Beyer, Thomas, Freudenberg, Lutz S., Townsend, David W., Czernin, Johannes
Foilsithe 2011

The future of hybrid imaging—part 2: PET/CT

le Beyer, Thomas, Townsend, David W., Czernin, Johannes, Freudenberg, Lutz S.
Foilsithe 2011

PET/CT in Oncology: Current Status and Perspectives

le Czernin, Johannes, Allen-Auerbach, Martin, Nathanson, David, Herrmann, Ken
Foilsithe 2013

Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites

le Fendler, Wolfgang Peter, Czernin, Johannes, Herrmann, Ken, Beyer, Thomas
Foilsithe in J Nucl Med (2016)

Positron Emission Tomography Reporter Genes and Reporter Probes: Gene and Cell Therapy Applications

le Yaghoubi, Shahriar S., Campbell, Dean O., Radu, Caius G., Czernin, Johannes
Foilsithe 2012

Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs

le Weber, Wolfgang A, Czernin, Johannes, Phelps, Michael E, Herschman, Harvey R
Foilsithe 2008

Stratification of Nucleoside Analog Chemotherapy Using 1-(2′-Deoxy-2′-(18)F-Fluoro-β-D-Arabinofuranosyl)Cytosine and 1-(2′-Deoxy-2′-(18)F-Fluoro-β-L-Arabinofuranosyl)-5-Methylcytos...

le Lee, Jason T., Campbell, Dean O., Satyamurthy, Nagichettiar, Czernin, Johannes, Radu, Caius G.
Foilsithe 2012

Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters

le Wieder, Hinrich A, Lassmann, Michael, Allen-Auerbach, Martin S, Czernin, Johannes, Herrmann, Ken
Foilsithe 2014

NI-68 (18)F-FDOPA PET IN TREATED LOW-GRADE GLIOMAS WITH NON-ENHANCING T2 CHANGES ON MRI IS PROGNOSTIC OF TUMOR PROGRESSION AND OVERALL SURVIVAL

le Schwarzenberg, Johannes, Czernin, Johannes, Cloughesy, Timothy, Lai, Albert, Phelps, Michael, Chen, Wei
Foilsithe 2014

Absolute Quantitation of Myocardial Blood Flow in Human Subjects with or without Myocardial Ischemia using Dynamic Flurpiridaz F 18 Positron Emission Tomography

le Packard, René R. S., Huang, Sung-Cheng, Dahlbom, Magnus, Czernin, Johannes, Maddahi, Jamshid
Foilsithe in J Nucl Med (2014)

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

le Calais, Jeremie, Czernin, Johannes, Fendler, Wolfgang P., Elashoff, David, Nickols, Nicholas G.
Foilsithe in BMC Cancer (2019)